Page last updated: 2024-11-10

2-thioxo-4-thiazolidinecarboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-thioxo-4-thiazolidinecarboxylic acid: in urine of workers exposed to carbon disulfide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3034757
CHEBI ID166452
SCHEMBL ID3892885
MeSH IDM0099337

Synonyms (24)

Synonym
2-sulanylidene-1,3-thiazolidine-4-carboxylic acid
CHEBI:166452
20933-67-9
2-thioxothiazolidine-4-carboxylic acid
thiazolidine-2-thione-4-carboxylic acid
2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid
AKOS002298899
FT-0675200
2-thioxo-4-thiazolidinecarboxylic acid
4-thiazolidinecarboxylic acid, 2-thioxo-
2-thiothiazolidine-4-carboxylic acid
2-thiazolidinethione-4-carboxylic acid
F3339-0170
AKOS016328777
SCHEMBL3892885
4-carboxythiazolidine-2-thione
2-thioxo-1,3-thiazolidine-4-carboxylic acid #
VU0421976-2
J-013727
2-mercaptothiazoline-4-carboxylic acid
DTXSID20943223
(r)-2-thioxo-4-thiazolidinecarboxylic acid
(r)-thiazolidine-2-thione-4-carboxylic acid
SB45095

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The air concentration at which such adverse effects can first be observed is presently a subject of controversy."( Neurotoxicity of long-term low-level exposure to carbon disulphide: results of questionnaire, clinical neurological examination and neuropsychological testing.
Angerer, J; Bickel, A; Claus, D; Drexler, H; Lehnert, G; Neundörfer, B; Reinhardt, F; Ulm, K, 1997
)
0.3

Bioavailability

ExcerptReferenceRelevance
" Analysis of urinary TTCA proved to be useful both for establishing the in vivo release of CS2 by dithiocarbamate containing compounds and for evaluating the bioavailability of CS2."( The measurement of 2-thiothiazolidine-4-carboxylic acid as an index of the in vivo release of CS2 by dithiocarbamates.
Amarnath, K; Amarnath, V; Graham, DG; Johnson, DJ; Valentine, WM,
)
0.13

Dosage Studied

ExcerptRelevanceReference
" After oral dosing (10 mg/rat), PB had an inhibiting effect on the excretion rate of TTCA."( Effect of cytochrome P450 isozyme induction and glutathione depletion on the metabolism of CS2 to TTCA in rats.
Aitio, A; Elovaara, E; Kivistö, H; Riihimaki, V, 1995
)
0.29
" The results of this preliminary study indicate that analysis of TTCA, although regarded as an established biomarker, can give biases and thus negatively interfere with inferred dose-effect or dose-response relationships in occupational epidemiology."( Preliminary external quality assessment for the biological monitoring of carbon disulfide with urinary 2-thiothiazolidine-4-carboxylic acid.
Braeckman, L; Bulat, P; Daemen, E; de Bacquer, D; van Risseghem, M; Vanhoorne, M, 1999
)
0.3
" Cardiovascular parameters included blood pressure, total, LDL and HDL cholesterol, triglycerides, C-reactive protein dosed in serum with high sensitivity (HsCRP), N-terminal pro-brain natriuretic peptide, and albuminuria/creatininuria ratio (UACR)."( No evidence of cardiovascular toxicity in workers exposed below 5 ppm carbon disulfide.
Domergue, J; Haufroid, V; Lison, D, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organonitrogen compoundAny heteroorganic entity containing at least one carbon-nitrogen bond.
organooxygen compoundAn organochalcogen compound containing at least one carbon-oxygen bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (62)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (14.52)18.7374
1990's23 (37.10)18.2507
2000's13 (20.97)29.6817
2010's9 (14.52)24.3611
2020's8 (12.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.61 (24.57)
Research Supply Index4.28 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.43%)5.53%
Reviews4 (5.71%)6.00%
Case Studies1 (1.43%)4.05%
Observational0 (0.00%)0.25%
Other64 (91.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]